erythromycin

Generic: erythromycin

Labeler: wilshire pharmaceuticals
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name erythromycin
Generic Name erythromycin
Labeler wilshire pharmaceuticals
Dosage Form TABLET, DELAYED RELEASE
Routes
ORAL
Active Ingredients

erythromycin 333 mg/1

Manufacturer
Wilshire Pharmaceuticals

Identifiers & Regulatory

Product NDC 52536-183
Product ID 52536-183_292b4c82-0b72-5283-e063-6394a90ad2ac
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA062298
Listing Expiration 2026-12-31
Marketing Start 2019-07-22

Pharmacologic Class

Established (EPC)
macrolide [epc] macrolide antimicrobial [epc]
Chemical Structure
macrolides [cs]
Physiologic Effect
decreased sebaceous gland activity [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 52536183
Hyphenated Format 52536-183

Supplemental Identifiers

RxCUI
310155 310157 315090
UNII
63937KV33D
NUI
N0000009982 N0000175877 N0000175935 M0028311

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name erythromycin (source: ndc)
Generic Name erythromycin (source: ndc)
Application Number ANDA062298 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 333 mg/1
source: ndc
Packaging
  • 30 TABLET, DELAYED RELEASE in 1 BOTTLE (52536-183-03)
  • 100 TABLET, DELAYED RELEASE in 1 BOTTLE (52536-183-10)
source: ndc

Packages (2)

52536-183-03 30 TABLET, DELAYED RELEASE in 1 BOTTLE (52536-183-03) 52536-183-10 100 TABLET, DELAYED RELEASE in 1 BOTTLE (52536-183-10)

Ingredients (1)

erythromycin (333 mg/1)

Linked Drug Pages (1)

Erythromycin ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "292b4c82-0b72-5283-e063-6394a90ad2ac", "openfda": {"nui": ["N0000009982", "N0000175877", "N0000175935", "M0028311"], "unii": ["63937KV33D"], "rxcui": ["310155", "310157", "315090"], "spl_set_id": ["e9b5abbb-2952-44ce-8cbb-415d9be23df4"], "pharm_class_cs": ["Macrolides [CS]"], "pharm_class_pe": ["Decreased Sebaceous Gland Activity [PE]"], "pharm_class_epc": ["Macrolide [EPC]", "Macrolide Antimicrobial [EPC]"], "manufacturer_name": ["Wilshire Pharmaceuticals"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, DELAYED RELEASE in 1 BOTTLE (52536-183-03)", "package_ndc": "52536-183-03", "marketing_start_date": "20190722"}, {"sample": false, "description": "100 TABLET, DELAYED RELEASE in 1 BOTTLE (52536-183-10)", "package_ndc": "52536-183-10", "marketing_start_date": "20190722"}], "brand_name": "Erythromycin", "product_id": "52536-183_292b4c82-0b72-5283-e063-6394a90ad2ac", "dosage_form": "TABLET, DELAYED RELEASE", "pharm_class": ["Decreased Sebaceous Gland Activity [PE]", "Macrolide Antimicrobial [EPC]", "Macrolide [EPC]", "Macrolides [CS]"], "product_ndc": "52536-183", "generic_name": "Erythromycin", "labeler_name": "Wilshire Pharmaceuticals", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Erythromycin", "active_ingredients": [{"name": "ERYTHROMYCIN", "strength": "333 mg/1"}], "application_number": "ANDA062298", "marketing_category": "ANDA", "marketing_start_date": "20190722", "listing_expiration_date": "20261231"}